An Overview of COVID-19 Patients in RSUD Bhakti Dharma Husada Surabaya from September 2020 to June 2021
Downloads
The COVID-19 pandemic has been lasting more than a year. Until now, research on the analysis of an overview of COVID-19patients has not been carried out at RSUD Bhakti Dharma Husada Surabaya. This study aims to describe the COVID-19 cases in RSUD Bhakti Dharma Husada Surabaya about the gender of patients, highest number of patients, the most recovered patient, the highest death rate occurred, and Case Fatality rate (CFR). This study is a descriptive observational study with a case series approach. The data used in this study were COVID-19 data from the application of online Hospital ditjen yankes from September 2020 to June 2021. The majority of COVID-19 cases occured in women (53.04 %). The COVID-19 patients mostly came to the hospital in June 2021, about 241. The most recovered patients in Oktober were 255 patients. The highest death rates occurred in June 2021 ware 47 patients. Case Fatality rate (CFR) is at 5.79 % because in June 2021 the health facilities were full, and cause patients did not get help quickly. Many patients have been forced to self-isolate at home so that they have worsened and ï¬ nally died. Most COVID-19 patients who were treated at the RSUD Bhakti Dharma Husada Surabaya from 2020 to June 2021 occurred in women and the most patients who were admitted was in June 2021.
Centers for Disease Control and Prevention (CDC). Novel Coronavirus (2019-nCoV) [Internet]. 2020. [cited 2021]
The Health Ministry of Indonesia. The decree of health ministry No HK.01.07/Menkes/413/2020 about guidance for prevention of Coronavirus disease 2019 (Covid-19). Jakarta; 2020
BNPB Task Force Dashboard [Internet]. 2021. [cited 2021 Jule 15]. Available from:https://covid19.go.id/)
The Health Ministry of Indonesia.Hospital management Information system. Ditjen Yankes.2021 http://sirs. kemkes.go.id/versi . [cited 2021 July 15].
Government of East java. Info Covid-19 Jatim. 2021 https://infocovid19.jatimprov.go.id/ [cited 2021 July 10].
Government City of Surabaya. Surabaya Lawan Covid- 19.2021 https://lawancovid-19.surabaya.go.id/ [cited 2021 July 10].
Putri NA, Putra AE, Mariko R. Hubungan Usia, Jenis Kelamin Dan Gejala Dengan Kejadian COVID-19 di Sumatera Barat. Majalah Kedokteran Andalas. 2021 Jul 9;44(2):104-11.
Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. Journal of Infection. 2020 Jul 1;81(1):1-9.
WHO, Scince in 5 on COVID-19 : Delta Variant [Internet]. 2021 [cited 2021 August 20]. Available from:https://www.who.int/emergenciesdiseases/ novel-coronavirus-2019/media-resources/sciencein-5/episode-45---delta-variant
Budhiraja S, Indrayan A, Aggarwal M, Jha V, Jain D, Tarai B, Das P, Aggarwal B, Mishra RS, Bali S, Mahajan M. Differentials in the characteristics of COVID-19 cases in Wave-1 and Wave-2 admitted to a network of hospitals in North India. medRxiv. 2021 Jan 1.
N Pierre. Reduction in mobility and COVID-19 transmission.Nature Comminications.2021 [cited 2021 September 9] https://www.nature.com/articles/ s41467- 021-21358-2.pdf
Hughes RP, Hughes DA. Impact of relaxing Covid- 19 social distancing measures on rural North Wales: a simulation analysis. Frontiers in Public Health. 2020;8:933.
Chen S, Chen Q, Yang W, Xue L, Liu Y, Yang J, Wang C, Bärnighausen T. Buying time for an effective epidemic response: the impact of a public holiday for outbreak control on COVID-19 epidemic spread. Engineering. 2020 Oct 1;6(10):1108-14.
A Surianta.Bekerja Sama Melawan Pandemi: Meningkatkan Kapasitas Vaksinasi Covid-19 di
Indonesia.Makalah kebijakan No 41.Covid- 19 di Indonesia.2021. cited 2021 September 9]
repository.cipsindonesia.org/tr/publications/348277/ bekerja-sama-melawan-pandemi-meningkatkan- kapasitas-vaksinasi-covid-19-di-indonesia
CNN Indonesia :Satgas: Kematian Covid-19 pada Juni Tertinggi Selama Pandemi[Internet]. 2021. [cited 2021 August 20]. Available from: https:// www.cnnindonesia. com/nasional/2021070610100120-663693/satgas- kematian-covid-19-pada-junitertinggi-selama- pandemi.
R E Jordan.Covid-19: risk factors for severe disease and death. Thebjm.2021. [cited 2021 August 20]. Available from:https://www.bmj.com/content/368/ bmj.m1198. long
Jain V, Duse A, Bausch DG. Planning for large epidemics and pandemics: challenges from a policy perspective. Current opinion in infectious diseases. 2018 Aug 1;31(4):316-24.
WHO.Considerations for implementing and adjusting public health and social measures in the context of COVID-19 2021 [cited 2021 September 9]. Available from: https://apps.who.int/iris/bitstream/ handle/10665/341811/WHO-2019-nCoV-Adjusting- PH-measures-2021.1-eng.pdf
Gan CC, Tseng YC, Lee KI. Acrylic window as physical barrier for Personal Protective Equipment (PPE) conservation. The American journal of emergency medicine. 2020 Jul 1;38(7):1532-4.
Provenzano DA, Sitzman BT, Florentino SA, Buterbaugh GA. Clinical and economic strategies in outpatient medical care during the COVID-19 pandemic. Regional Anesthesia & Pain Medicine. 2020 Aug 1;45(8):579-85.
Glik DC. Risk communication for public health emergencies. Annu. Rev. Public Health. 2007 Apr 21;28:33-54.
Leung K, Wu JT, Leung GM. Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study. The Lancet Public Health. 2021 Aug 11.
Gan CC, Dwirahmadi F. How Can The Public be Better Protected Against Covid-19?. Jurnal Berkala Epidemiologi. 2020 May 31;8(2):97-9.
Gille F, Brall C. Public trust: caught between hype and need. International Journal of Public Health.2020.65(3), 233–234.
Aldrich DP, Oum S, Sawada Y, editors. Resilience and recovery in Asian disasters: Community ties, market mechanisms, and governance. Tokyo: Springer Japan; 2015.
WHO, Gender and Covid-19 : 2020 [cited 2021 August 20]. Available from: https://apps.who.int/iris/ bitstream/handle/10665/332080/WHO-2019-nCoV- Advocacy_brief-Gender-2020.1-eng.pd
Copyright (c) 2022 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
